PAVM News and Press, PAVmed Inc.

Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026 PR Newswire Conference Call and Webcast at 8:30 AM ET NEW YORK , March 12, 2026 /PRNewswire/ --  Lucid Diagnostics Inc.   (Nasdaq: LUCD)  ...

PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities PR Newswire Series D Preferred Stock offering yielded $30 million of gross proceeds and includes warrants exercisable for up to an additional $30 milli...

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 9.2% to $1.97 on volume of 580,256,206 shares Intel Corporation (INTC) rose 11.7% to $54.25 on volume of 220,565,312 shares NVIDIA Corporation (NVDA) rose 2.9% to $183.32 on volume...

2026-01-21 15:40:49 ET PAVmed Inc (NASDAQ: PAVM) shares more than quadrupled on Wednesday after the company’s subsidiary – Lucid Diagnostics – secured a major contract from the US government. According to PAVM’s press release , the US Department of Ve...

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 11.5% to $1.92 on volume of 525,100,160 shares Intel Corporation (INTC) rose 11.2% to $53.995 on volume of 177,546,761 shares ProShares UltraShort Silver -2x Shares (ZSL) rose 6.6%...

2026-01-21 08:47:16 ET More on Lucid Diagnostics, PAVmed PAVmed Inc. (PAVM) Shareholder/Analyst Call Prepared Remarks Transcript Lucid Diagnostics Inc. 2025 Q3 - Results - Earnings Call Presentation PAVmed Inc. 2025 Q3 - Results - Earnings Call Presentation P...

Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® PR Newswire NEW YORK , Jan. 21, 2026 /PRNewswire/ -- Lucid Diagnostics Inc.  (Nasdaq: LUCD)  ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagn...

2025-12-30 09:29:01 ET More on PAVmed, Lucid Diagnostics PAVmed Inc. (PAVM) Shareholder/Analyst Call Prepared Remarks Transcript Lucid Diagnostics Inc. 2025 Q3 - Results - Earnings Call Presentation PAVmed Inc. 2025 Q3 - Results - Earnings Call Presentation L...

PAVmed Announces Reverse Stock Split PR Newswire NEW YORK , Dec. 30, 2025 /PRNewswire/ --  PAVmed Inc.  (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital...

Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection PR Newswire Report includes nearly 12,000 patients who underwent Lucid's EsoGuard ® Esophageal DNA Test on samples collected using its EsoCheck ® ...